Leukine - 58468-0181-2 - (sargramostim)

Alphabetical Index


Drug Information of Leukine

Product NDC: 58468-0181
Proprietary Name: Leukine
Non Proprietary Name: sargramostim
Active Ingredient(s): 500    ug/mL & nbsp;   sargramostim
Administration Route(s): INTRAVENOUS; SUBCUTANEOUS
Dosage Form(s): LIQUID
Coding System: National Drug Codes(NDC)

Labeler Information of Leukine

Product NDC: 58468-0181
Labeler Name: Genzyme Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA103362
Marketing Category: BLA
Start Marketing Date: 20100315

Package Information of Leukine

Package NDC: 58468-0181-2
Package Description: 5 VIAL in 1 CARTON (58468-0181-2) > 1 mL in 1 VIAL

NDC Information of Leukine

NDC Code 58468-0181-2
Proprietary Name Leukine
Package Description 5 VIAL in 1 CARTON (58468-0181-2) > 1 mL in 1 VIAL
Product NDC 58468-0181
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name sargramostim
Dosage Form Name LIQUID
Route Name INTRAVENOUS; SUBCUTANEOUS
Start Marketing Date 20100315
Marketing Category Name BLA
Labeler Name Genzyme Corporation
Substance Name SARGRAMOSTIM
Strength Number 500
Strength Unit ug/mL
Pharmaceutical Classes Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC]

Complete Information of Leukine


General Information